Litcius/Paper detail

Atosiban versus placebo for threatened preterm birth (APOSTEL 8): a multicentre, randomised controlled trial

Larissa I. van der Windt, Job Klumper, Ruben G. Duijnhoven, Marjolein Kok, Carrie Ris‐Stalpers, Marjon A. de Boer, Anton H. van Kaam, Eva Pajkrt, Ben W. Mol, Kate F. Walker, Fionnuala M. McAuliffe, Joris van der Post, Carolien Roos, Martijn A. Oudijk, Jelle Schaaf, Jim van Eyck, H.M. Knol, Marieke Sueters, Liesbeth Scheepers, David P. van der Ham, Judith O. E. H. van Laar, Eline S.A. van den Akker, Ralph R. Scholten, Nicolette van Gemund, Karlijn C. Vollebregt, Harrie Visser, Sanne J. Gordijn, Mireille N. Bekker, Josje Langenveld

2025The Lancet14 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePlaceboRandomized controlled trialObstetricsThreatened speciesInternal medicineAlternative medicineBiologyEcologyPathologyHabitatPreterm Birth and ChorioamnionitisNeonatal Respiratory Health ResearchNeonatal and fetal brain pathology